NEULAND LABORATORIES
|
NEULAND LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity - Authorised | ₹44 Cr | ₹44 Cr | ₹44 Cr | ₹44 Cr | ₹44 Cr |
Equity - Issued | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity Paid Up | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity Shares Forfeited | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹981 Cr | ₹828 Cr | ₹774 Cr | ₹697 Cr | ₹686 Cr |
Securities Premium | ₹498 Cr | ₹498 Cr | ₹498 Cr | ₹498 Cr | ₹498 Cr |
Capital Reserves | ₹0.03 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.03 Cr |
Profit & Loss Account Balance | ₹465 Cr | ₹308 Cr | ₹248 Cr | ₹170 Cr | ₹159 Cr |
General Reserves | ₹28 Cr | ₹28 Cr | ₹28 Cr | ₹28 Cr | ₹28 Cr |
Other Reserves | ₹-9.74 Cr | ₹-6.24 Cr | ₹-0.31 Cr | ₹1.26 Cr | ₹1.69 Cr |
Reserve excluding Revaluation Reserve | ₹980 Cr | ₹827 Cr | ₹773 Cr | ₹696 Cr | ₹686 Cr |
Revaluation reserve | ₹0.84 Cr | ₹0.84 Cr | ₹0.84 Cr | ₹0.84 Cr | ₹0.84 Cr |
Shareholder's Funds | ₹994 Cr | ₹841 Cr | ₹786 Cr | ₹710 Cr | ₹699 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹74 Cr | ₹104 Cr | ₹88 Cr | ₹77 Cr | ₹61 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹106 Cr | ₹135 Cr | ₹110 Cr | ₹68 Cr | ₹54 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-32 Cr | ₹-30 Cr | ₹-22 Cr | ₹9.31 Cr | ₹6.42 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹58 Cr | ₹57 Cr | ₹60 Cr | ₹48 Cr | ₹11 Cr |
Deferred Tax Assets | ₹14 Cr | ₹17 Cr | ₹10 Cr | ₹19 Cr | ₹70 Cr |
Deferred Tax Liability | ₹72 Cr | ₹73 Cr | ₹70 Cr | ₹67 Cr | ₹81 Cr |
Other Long Term Liabilities | ₹3.88 Cr | ₹6.97 Cr | ₹12 Cr | ₹26 Cr | ₹20 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹10 Cr | ₹12 Cr | ₹9.44 Cr | ₹12 Cr | ₹12 Cr |
Total Non-Current Liabilities | ₹147 Cr | ₹180 Cr | ₹170 Cr | ₹163 Cr | ₹104 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹171 Cr | ₹117 Cr | ₹152 Cr | ₹116 Cr | ₹120 Cr |
Sundry Creditors | ₹171 Cr | ₹117 Cr | ₹152 Cr | ₹116 Cr | ₹120 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹245 Cr | ₹152 Cr | ₹159 Cr | ₹72 Cr | ₹57 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹137 Cr | ₹63 Cr | ₹64 Cr | ₹22 Cr | ₹15 Cr |
Interest Accrued But Not Due | ₹0.25 Cr | ₹0.33 Cr | ₹0.40 Cr | ₹0.25 Cr | ₹0.29 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹108 Cr | ₹89 Cr | ₹95 Cr | ₹50 Cr | ₹42 Cr |
Short Term Borrowings | ₹11 Cr | ₹92 Cr | ₹57 Cr | ₹168 Cr | ₹149 Cr |
Secured ST Loans repayable on Demands | ₹11 Cr | ₹92 Cr | ₹57 Cr | ₹168 Cr | ₹149 Cr |
Working Capital Loans- Sec | ₹11 Cr | ₹92 Cr | ₹57 Cr | ₹168 Cr | ₹149 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-11 Cr | ₹-92 Cr | ₹-57 Cr | ₹-168 Cr | ₹-149 Cr |
Short Term Provisions | ₹12 Cr | ₹1.21 Cr | ₹0.64 Cr | ₹2.27 Cr | ₹0.80 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹10 Cr | - | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹1.53 Cr | ₹1.21 Cr | ₹0.64 Cr | ₹2.27 Cr | ₹0.80 Cr |
Total Current Liabilities | ₹439 Cr | ₹363 Cr | ₹369 Cr | ₹358 Cr | ₹327 Cr |
Total Liabilities | ₹1,580 Cr | ₹1,383 Cr | ₹1,325 Cr | ₹1,231 Cr | ₹1,130 Cr |
ASSETS | |||||
Gross Block | ₹953 Cr | ₹913 Cr | ₹826 Cr | ₹714 Cr | ₹575 Cr |
Less: Accumulated Depreciation | ₹215 Cr | ₹166 Cr | ₹130 Cr | ₹92 Cr | ₹64 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹738 Cr | ₹748 Cr | ₹697 Cr | ₹623 Cr | ₹512 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹41 Cr | ₹20 Cr | ₹17 Cr | ₹24 Cr | ₹104 Cr |
Non Current Investments | ₹0.53 Cr | ₹0.50 Cr | ₹0.44 Cr | ₹30 Cr | ₹30 Cr |
Long Term Investment | ₹0.53 Cr | ₹0.50 Cr | ₹0.44 Cr | ₹30 Cr | ₹30 Cr |
Quoted | ₹0.28 Cr | ₹0.25 Cr | ₹0.19 Cr | ₹0.11 Cr | ₹0.15 Cr |
Unquoted | ₹0.25 Cr | ₹0.25 Cr | ₹0.25 Cr | ₹30 Cr | ₹30 Cr |
Long Term Loans & Advances | ₹20 Cr | ₹14 Cr | ₹42 Cr | ₹36 Cr | ₹31 Cr |
Other Non Current Assets | - | - | - | ₹3.30 Cr | - |
Total Non-Current Assets | ₹819 Cr | ₹803 Cr | ₹775 Cr | ₹716 Cr | ₹677 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | ₹3.38 Cr | ₹6.46 Cr | ₹7.50 Cr | ₹7.50 Cr |
Quoted | - | - | - | - | - |
Unquoted | - | ₹3.38 Cr | ₹6.46 Cr | ₹7.50 Cr | ₹7.50 Cr |
Inventories | ₹279 Cr | ₹265 Cr | ₹248 Cr | ₹220 Cr | ₹193 Cr |
Raw Materials | ₹81 Cr | ₹78 Cr | ₹79 Cr | ₹55 Cr | ₹46 Cr |
Work-in Progress | ₹118 Cr | ₹119 Cr | ₹108 Cr | ₹110 Cr | ₹101 Cr |
Finished Goods | ₹64 Cr | ₹53 Cr | ₹49 Cr | ₹45 Cr | ₹40 Cr |
Packing Materials | - | - | - | - | - |
Stores Ā and Spare | ₹17 Cr | ₹15 Cr | ₹12 Cr | ₹9.13 Cr | ₹6.31 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹362 Cr | ₹234 Cr | ₹218 Cr | ₹190 Cr | ₹164 Cr |
Debtors more than Six months | ₹3.70 Cr | ₹4.13 Cr | ₹7.55 Cr | - | - |
Debtors Others | ₹362 Cr | ₹234 Cr | ₹214 Cr | ₹198 Cr | ₹168 Cr |
Cash and Bank | ₹59 Cr | ₹20 Cr | ₹19 Cr | ₹47 Cr | ₹38 Cr |
Cash in hand | ₹0.02 Cr | ₹0.02 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.04 Cr |
Balances at Bank | ₹59 Cr | ₹20 Cr | ₹19 Cr | ₹47 Cr | ₹38 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹14 Cr | ₹12 Cr | ₹8.84 Cr | ₹17 Cr | ₹20 Cr |
Interest accrued on Investments | ₹0.09 Cr | ₹0.07 Cr | ₹0.17 Cr | ₹0.65 Cr | ₹3.70 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹11 Cr | ₹7.42 Cr | ₹7.18 Cr | ₹6.08 Cr | ₹5.78 Cr |
Other current_assets | ₹3.07 Cr | ₹4.03 Cr | ₹1.50 Cr | ₹11 Cr | ₹10 Cr |
Short Term Loans and Advances | ₹47 Cr | ₹46 Cr | ₹50 Cr | ₹34 Cr | ₹32 Cr |
Advances recoverable in cash or in kind | ₹25 Cr | ₹21 Cr | ₹36 Cr | ₹14 Cr | ₹13 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹22 Cr | ₹25 Cr | ₹13 Cr | ₹20 Cr | ₹18 Cr |
Total Current Assets | ₹761 Cr | ₹581 Cr | ₹550 Cr | ₹515 Cr | ₹453 Cr |
Net Current Assets (Including Current Investments) | ₹322 Cr | ₹218 Cr | ₹181 Cr | ₹158 Cr | ₹126 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,580 Cr | ₹1,383 Cr | ₹1,325 Cr | ₹1,231 Cr | ₹1,130 Cr |
Contingent Liabilities | ₹91 Cr | ₹75 Cr | ₹105 Cr | ₹125 Cr | ₹107 Cr |
Total Debt | ₹122 Cr | ₹231 Cr | ₹170 Cr | ₹260 Cr | ₹231 Cr |
Book Value | 774.12 | 654.40 | 612.28 | 552.65 | 544.35 |
Adjusted Book Value | 774.12 | 654.40 | 612.28 | 552.65 | 544.35 |
Compare Balance Sheet of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹9,556.9 Cr | 3.7% | 15.5% | 263% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 3.7% |
15.5% |
263% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses